For example, suppression or down-regulation of DPP4 promotes prostate cancer progression via reduced degradation of its substrate CXCL12, leading to enhanced signalling via CXCR4 and increased invasion and metastatic spread to peripheral organs in vivo [40,41]. The gene discussed is CXCR4; the disease is prostate cancer.